Development and validation of an HPLC method for the simultaneous monitoring of bromazepam and omeprazole

Journal of Liquid Chromatography and Related Technologies

Volumn 31, Issue 6, 2008, Pages 878-890

  Podilsky, Gregory ^a   Berger Gryllaki, Markoulina ^a   Testa, Bernard ^a   Pannatier, André ^a,b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Bromazepam; HPLC; Omeprazole; Solid phase extraction; Therapeutic drug monitoring

Indexed keywords

EXTRACTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PATIENT TREATMENT;

BROMAZEPAM; OMEPRAZOLE; SOLID PHASE EXTRACTION; THERAPEUTIC DRUG MONITORING;

DRUG PRODUCTS;

BROMAZEPAM; OMEPRAZOLE; OXAZEPAM;

ACCURACY; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; DRUG STRUCTURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; QUANTITATIVE ANALYSIS; SINGLE DRUG DOSE; SOLID PHASE EXTRACTION; ULTRAVIOLET RADIATION;

EID: 39549112931     PISSN: 10826076     EISSN: 1520572X     Source Type: Journal    
DOI: 10.1080/10826070801893508     Document Type: Article

References (30)

1. Podilsky, G.; Roulet, M.; Pannatier, A. Administration des médicaments par sondes d'alimentation entérale: état des lieux dans 3 services médico-chirurgicaux; poster presented at Journée Franco-Suisses de Pharmacie Hospitalière: Genève, 2001.
2. Podilsky, G.; Roulet, M.; Pannatier, A. Administration des médicaments par sonde d'alimentation entérale. Etat des lieux et développement d'une méthode de dosage de quatre médicament dans une formule nutritive; Master of advanced studies in Hospital Pharmacy, University of Lausanne: Switzerland, 2002.
3. Hunkeler, W.; Mohler, H.; Pieri, L.; Polc, P.; Bonetti, E.P.; Cumin, R.; Schaffner, R.; Haefely, W. Selective antagonists of benzodiazepines. Nature 1981, 290 (5806), 514-516.
4. Goffinet, S. Mechanism of action, indications and abuse of benzodiazepine anxiolytic drugs. Ann. Med Psychol. (Paris) 1993, 151 (1), 47-63.
5. Johnston, M. Anxiety in surgical patients. Psychol. Med. 1980, 10 (1), 145-152.
6. Gomes, L.C.; Fraga, M.N. Illness, hospitalization and anxiety: an approach to mental health. Rev. Bras. Enferm. 1997, 50 (3), 425-440.
7. Wheatley, D. Use of anti-anxiety drugs in the medically ill. Psychother. Psychosom. 1988, 49 (2), 63-80.
8. Besancon, M.; Simon, A.; Sachs, G.; Shin, J.M. Sites of reaction of the gastric H,K-ATPase with extracytoplasmic thiol reagents. J. Biol. Chem. 1997, 272 (36), 22438-2246.
9. Nochi, S.; Yokoyama, Y.; Narukawa, M.; Ebine, K.; Murahashi, M.; Kawakami, Y.; Asakawa, N.; Sato, T. Mechanism of inhibition of H+, K(+)-ATPase by sodium 2-[[4-(3- methoxypropoxy)-3-methylpyridin-2-yl]methylsulfinyl]-1H- benzimidazole (E3810). Chem. Pharm. Bull. (Tokyo) 1996, 44 (3), 552-558.
10. Lind, T.; Megraud, F.; Unge, P.; Bayerdorffer, E.; O'Morain, C.; Spiller, R.; Veldhuyzen Van Zanten, S.; Bardhan, K.D.; Hellblom, M.; Wrangstadh, M.; Zeijlon, L.; Cederberg, C. The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. Gastroenterology 1999, 116 (2), 248-253.
11. Lasky, M.R.; Metzler, M.H.; Phillips, J.O. A prospective study of omeprazole suspension to prevent clinically significant gastrointestinal bleeding from stress ulcers in mechanically ventilated trauma patients. J. Trauma 1998, 44 (3), 527-533.
12. ASHP Commission on Therapeutics, ASHP Therapeutic Guidelines on Stress Ulcer Prophylaxis. Am. J. Health Syst. Pharm. 1999, 56 (4), 347-379.
13. DiGiacinto, J.L.; Olsen, K.M.; Bergman, K.L.; Hoie, E.B. Stability of suspension formulations of lansoprazole and omeprazole stored in amber-colored plastic oral syringes. Ann. Pharmacother. 2000, 34 (5), 600-605.
14. Sluggett, G.W.; Stong, J.D.; Adams, J.H.; Zhao, Z. Omeprazole determination using HPLC with coulometric detection. J. Pharm. Biomed. Anal. 2001, 25 (3-4), 357-361.
15. Quercia, R.A.; Fan, C.; Liu, X.; Chow, M.S. Stability of omeprazole in an extemporaneously prepared oral liquid. Am. J. Health Syst. Pharm. 1997, 54 (16), 1833-1836.
16. Rieck, W.; Platt, D. High-performance liquid chromatographic method for the determination of alprazolam in plasma using the column-switching technique. J. Chromatogr. 1992, 578 (2), 259-263.
17. Le Solleu, H.; Demotes-Mainard, F.; Vincon, G.; Bannwarth, B. The determination of bromazepam in plasma by reversed-phase high-performance liquid chromatography. J. Pharm. Biomed. Anal. 1993, 11 (8), 771-775.
18. Boukhabza, A.; Lugnier, A.A.; Kintz, P.; Tracqui, A.; Mangin, P.; Chaumont, A.J. High-performance liquid chromatographic determination of bromazepam in human plasma. Analyst 1989, 114 (5), 639-641.
19. Macek, J.; Ptacek, P.; Klima, J. Determination of omeprazole in human plasma by high-performance liquid chromatography. J. Chromatogr. B Biomed. Sci. Appl. 1997, 689 (1), 239-243.
20. Motevalian, M.; Saeedi, G.; Keyhanfar, F.; Tayebi, L.; Mahmoudian, M. Simultaneous determination of omeprazole and its metabolites in human plasma by HPLC using Solid-phase extraction. Pharm. Pharmacol. Commun. 1999, 5, 265-268.
21. Tanaka, E.; Terada, M.; Misawa, S.; Wakasugi, C. Simultaneous determination of twelve benzodiazepines in human serum using a new reversed-phase chromatographic column on a 2-microns porous microspherical silica gel. J. Chromatogr. B Biomed. Appl. 1996, 682 (1), 173-178.
22. Commission SFSTP, Validation des procédures analytiques quantitatives. Harmonisation des démarches. STP Pharma Pratiques 2003, 13 (3), 101-138.
23. Ohtani, Y.; Kotegawa, T.; Tsutsumi, K.; Morimoto, T.; Hirose, Y.; Nakano, S. Effect of fluconazole on the pharmacokinetics and pharmacodynamics of oral and rectal bromazepam: an application of electroencephalography as the pharmacodynamic method. J. Clin. Pharmacol. 2002, 42 (2), 183-191.
24. Schwartz, M.A.; Postma, E.; Kolis, S.J.; Leon, A.S. Metabolites of bromazepam, a benzodiazepine, in the human, dog, rat, and mouse. J. Pharm. Sci. 1973, 62 (11), 1776-1779.
25. Lagerstrom, P.O.; Persson, B.A. Determination of omeprazole and metabolites in plasma and urine by liquid chromatography. J. Chromatogr. 1984, 309 (2), 347-356.
26. Lerner, F.E.; Schere, D.; Batafarano, N.; Casas, F.; Glancszpigel, R. Comparative bioavailability of two oral formulations of bromazepam in healthy volunteers. Arzneimittelforschung 2001, 51 (12), 955-958.
27. Orlando, R.M.; Bonato, P.S. Simple and efficient method for enantioselective determination of omeprazole in human plasma. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2003, 795 (2), 227-235.
28. Kang, B.C.; Yang, C.Q.; Cho, H.K.; Suh, O.K.; Shin, W.G. Influence of fluconazole on the pharmacokinetics of omeprazole in healthy volunteers. Biopharm. Drug Dispos. 2002, 23 (2), 77-81.
29. Garcia-Encina, G.; Farran, R.; Puig, S.; Martinez, L. Validation of an automated liquid chromatographic method for omeprazole in human plasma using on-line solid-phase extraction. J. Pharm. Biomed. Anal. 1999, 21 (2), 371-382.
30. Rezk, N.L.; Brown, K.C.; Kashuba, A.D. A simple and sensitive bioanalytical assay for simultaneous determination of omeprazole and its three major metabolites in human blood plasma using RP-HPLC after a simple liquid-liquid extraction procedure. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 2006, 844 (2), 314-321.